Immunologists at Instituto de Investigação e Inovação em Saúde (i3S) in Porto, Portugal, are using INTEGRA Biosciences laboratory tools to help further our understanding of the human immune system.

Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline.

The collaborative center will help to lower barriers to RNA innovation and discovery.

Latest real-world metric in Phesi’s AI-driven Trial Accelerator™ quantifies patient burden to unlock a patient-centric approach to trial design and implementation.

Ascelia Pharma AB (publ) (ticker: ACE), announced that liver imaging drug candidate, Orviglance®, significantly improved visualization of focal liver lesions, successfully meeting the primary endpoint in the pivotal Phase 3 study SPARKLE.

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples.

Nuclera, announced it has successfully completed 11 installs of its eProtein Discovery™ system, including at leading academic institutes.

Sino Biological, Inc. ("Sino Biological" or the "Company”), has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.

Olden Labs emerges from stealth to unveil a new approach to animal research. By harnessing artificial intelligence (AI), genetic engineering and robotics, Olden Labs is building the world’s first automated animal research lab.

Agilent Technologies Inc. has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility.